Lysosome targeted drugs: rhodamine B modified N^N-chelating ligands for half-sandwich iridium(<scp>iii</scp>) anticancer complexes

DOI Web Site 2 Citations
  • Wenli Ma
    Institute of Anticancer Agents Development and Theranostic Application
  • Zhenzhen Tian
    Institute of Anticancer Agents Development and Theranostic Application
  • Shumiao Zhang
    Institute of Anticancer Agents Development and Theranostic Application
  • Xiangdong He
    Institute of Anticancer Agents Development and Theranostic Application
  • JuanJuan Li
    Institute of Anticancer Agents Development and Theranostic Application
  • Xiaorong Xia
    Institute of Anticancer Agents Development and Theranostic Application
  • Xiaobing Chen
    Institute of Anticancer Agents Development and Theranostic Application
  • Zhe Liu
    Institute of Anticancer Agents Development and Theranostic Application

Description

<p>We designed and synthesized four rhodamine-modified half-sandwich iridium complexes ([(η5-Cpx)Ir(N^N)Cl]PF6).</p>

Journal

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top